Arbutus Biopharma Corp
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $137.1M
Liabilities Breakdown FY2020
Total Liabilities: $35.1M
Asset Breakdown
Total Assets: $137.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $52.3M | 38.1% |
| Accounts Receivable | $1.3M | 1.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.9M | 5.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $76.6M | 55.9% |
Liabilities Breakdown
Total Liabilities: $35.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 8.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $32.1M | 91.5% |